Literature DB >> 25043672

High mobility group box 1 protein (HMGB-1): a pathogenic role in preeclampsia?

P-A Pradervand1, S Clerc2, J Frantz2, C Rotaru2, D Bardy3, B Waeber4, L Liaudet5, Y Vial6, F Feihl2.   

Abstract

We evaluated whether preeclampsia is associated with elevated circulating levels of High mobility group box 1 protein (HMGB-1), a nuclear protein with proinflammatory effects when released extracellularly. We enrolled 48 women, 32 in third trimester pregnancy (16 with, 16 without preeclampsia), and 16 healthy non pregnant. In the peripheral blood of pregnant women, HMGB-1 concentration was assessed serially, before and after delivery. With or without preeclampsia, third trimester pregnancy was associated with elevated levels of HMGB-1. This elevation is exaggerated in preeclampsia. The source of HMGB-1 observed in these conditions is likely to involve tissues other than the placenta itself.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  High mobility group box-1 protein; Inflammation; Preeclampsia

Mesh:

Substances:

Year:  2014        PMID: 25043672     DOI: 10.1016/j.placenta.2014.06.370

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  9 in total

1.  Gene Expression of Pregnancy Neutrophils Differs for Protease versus Lipopolysaccharide Stimulation.

Authors:  Scott W Walsh; Marwah Al Dulaimi; Jerome F Strauss
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

2.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

3.  The HMGB1/RAGE Pro-Inflammatory Axis in the Human Placenta: Modulating Effect of Low Molecular Weight Heparin.

Authors:  Cristian Zenerino; Anna Maria Nuzzo; Domenica Giuffrida; Marilisa Biolcati; Alessandra Zicari; Tullia Todros; Alessandro Rolfo
Journal:  Molecules       Date:  2017-11-17       Impact factor: 4.411

Review 4.  Role of the NLRP3 Inflammasome in Preeclampsia.

Authors:  Koumei Shirasuna; Tadayoshi Karasawa; Masafumi Takahashi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-25       Impact factor: 5.555

5.  Second-trimester serum high mobility group box-1 and uterine artery Doppler to predict preeclampsia.

Authors:  Varangkana Wairachpanich; Vorapong Phupong
Journal:  Sci Rep       Date:  2022-04-27       Impact factor: 4.996

Review 6.  High-mobility group box 1 is a driver of inflammation throughout pregnancy.

Authors:  Chelsea A Saito Reis; Justin G Padron; Nainoa D Norman Ing; Claire E Kendal-Wright
Journal:  Am J Reprod Immunol       Date:  2020-09-17       Impact factor: 3.886

7.  Increased cell-free fetal DNA release after apoptosis and sterile inflammation in human trophoblast cells.

Authors:  Nazanin Yeganeh Kazemi; Bohdana Fedyshyn; Isabel Yelsa; Yaroslav Fedyshyn; Rodrigo Ruano; Svetomir N Markovic; Rana Chakraborty; Elizabeth Ann L Enninga
Journal:  Am J Reprod Immunol       Date:  2021-07-20       Impact factor: 3.886

8.  Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome.

Authors:  Valeria Manganelli; Antonella Capozzi; Simona Truglia; Cristiano Alessandri; Emanuela Lococo; Tina Garofalo; Caterina De Carolis; Fabrizio Conti; Guido Valesini; Maurizio Sorice; Agostina Longo; Roberta Misasi
Journal:  J Immunol Res       Date:  2017-12-19       Impact factor: 4.818

9.  Hypoxia and oxidative stress induce sterile placental inflammation in vitro.

Authors:  Bernadette C Baker; Alexander E P Heazell; Colin Sibley; Rachael Wright; Helen Bischof; Frances Beards; Tatiana Guevara; Sylvie Girard; Rebecca L Jones
Journal:  Sci Rep       Date:  2021-03-31       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.